ASTRAZEN AstraZeneca Pharma gets India’s Regulator, ‘Central Drugs Standard Control Organisation (CDSCO)’ approval
ASTRAZEN AstraZeneca Pharma gets India’s Regulator, ‘Central Drugs Standard Control Organisation (CDSCO)’ approval to import for sale & distribution of Durvalumab solution'
Alert: Durvalumab Is Used To Treat Patients With Limited-Stage Small Cell Lung Cancer
#Today’sTradingSetup#StockInNews#TechnicalViews#FundamentalViews#SectorBreakouts

162 likes·47 comments

















